INSULIN GLARGINE — all Canadian products
12 DINs
9 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is INSULIN GLARGINE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02444844 | BASAGLAR | ELI LILLY CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT | Marketed | |
| 02461528 | BASAGLAR | ELI LILLY CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT | Marketed | |
| 02294338 | LANTUS | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT | Marketed | |
| 02245689 | LANTUS | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT | Marketed | |
| 02251930 | LANTUS | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT | Marketed | |
| 02526441 | SEMGLEE | BIOCON SDN.BHD | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT | Marketed | |
| 02478293 | SOLIQUA | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT; LIXISENATIDE 33 MCG | Marketed | |
| 02493373 | TOUJEO DOUBLESTAR | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 300 UNIT | Marketed | |
| 02441829 | TOUJEO SOLOSTAR | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 300 UNIT | Marketed | |
| 02444852 | BASAGLAR | ELI LILLY CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT | Cancelled Post Market | |
| 02276410 | LANTUS | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT | Cancelled Pre Market | |
| 02280418 | LANTUS | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN GLARGINE 100 UNIT | Cancelled Pre Market |
Browse other molecules: